BlackRock Advisors’s Fortress Biotech FBIO Stock Holding History

BlackRock Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$55K	Buy	1,368 +46	+3%	+$1.72K	﹤0.01%	3231
2016 Q3	$59K	Buy	1,322 +268	+25%	+$11.4K	﹤0.01%	3199
2016 Q2	$43K	Buy	1,054 +600	+132%	+$27.9K	﹤0.01%	3261
2016 Q1	$21K	Hold	454	–	–	﹤0.01%	3419
2015 Q4	$19K	Hold	454	–	–	﹤0.01%	3500
2015 Q3	$18K	Hold	454	–	–	﹤0.01%	3539
2015 Q2	$23K	Hold	454	–	–	﹤0.01%	3475
2015 Q1	$26K	Hold	454	–	–	﹤0.01%	3395
2014 Q4	$17K	Buy	+454	New	+$13.4K	﹤0.01%	3538
2014 Q3	–	Sell	-984	Closed	-$25K	–	3692
2014 Q2	$25K	Sell	984 -1,044	-51%	-$27.5K	﹤0.01%	3393
2014 Q1	$60K	Buy	2,028 +554	+38%	+$21.6K	﹤0.01%	3205
2013 Q4	$58K	Buy	1,474 +171	+13%	+$6.6K	﹤0.01%	3207
2013 Q3	$137K	Buy	1,303 +386	+42%	+$47.3K	﹤0.01%	2765
2013 Q2	$118K	Buy	+917	New	+$135K	﹤0.01%	2782

Other funds holding FBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAM

ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BlackRock Advisors's FBIO Position: Q4 2016 in Review

BlackRock Advisors increased its Fortress Biotech (FBIO) stake by 3.5% in Q4 2016, buying an estimated $1.72K and bringing the position to 1,368 shares worth $55K. The position accounts for ﹤0.01% of the portfolio, ranked #3231.

BlackRock Advisors first reported a position in FBIO in Q2 2013 and has held it in 14 quarters since. The position peaked at $137K in Q3 2013. 51 funds tracked by Wall St. Rank hold FBIO as of Q4 2016.

BlackRock Advisors held 1,368 shares of Fortress Biotech worth $55K as of Q4 2016.
BlackRock Advisors bought 46 Fortress Biotech shares in Q4 2016, an estimated $1.72K.
Fortress Biotech made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3231 holding.
BlackRock Advisors first reported a position in Fortress Biotech in Q2 2013 and has held it in 14 quarters since.
BlackRock Advisors's Fortress Biotech position peaked at $137K in Q3 2013.
51 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.